xeljanz
pfizer limited - Тофацитиниб - zapalenie stawów, reumatoidalne - leki immunosupresyjne - leczenie reumatoidalnego zapalenia stawów.
xeljanz
pfizer europe ma eeig - Тофацитиниб - zapalenie stawów, reumatoidalne - leki immunosupresyjne - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 i 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.
apoquel
zoetis belgium sa - maleinian oclacitinib - Środki do zapalenia skóry, z wyłączeniem kortykosteroidy - psy - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.
mycomax 2 mg/ml roztwór do infuzji
zentiva, k.s. - fluconazolum - roztwór do infuzji - 2 mg/ml
flukonazol actavis 50 mg kapsułki twarde
actavis group ptc ehf. - fluconazolum - kapsułki twarde - 50 mg
flukonazol actavis 100 mg kapsułki twarde
actavis group ptc ehf. - fluconazolum - kapsułki twarde - 100 mg
flukonazol actavis 150 mg kapsułki twarde
actavis group ptc ehf. - fluconazolum - kapsułki twarde - 150 mg
flukonazol actavis 200 mg kapsułki twarde
actavis group ptc ehf. - fluconazolum - kapsułki twarde - 200 mg
flukofemin one 150 mg tabletka
przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - fluconazolum - tabletka - 150 mg
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - Środki przeciwnowotworowe - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.